1. Home
  2. WVE vs EIG Comparison

WVE vs EIG Comparison

Compare WVE & EIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • EIG
  • Stock Information
  • Founded
  • WVE 2012
  • EIG 2000
  • Country
  • WVE Singapore
  • EIG United States
  • Employees
  • WVE N/A
  • EIG N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • EIG Property-Casualty Insurers
  • Sector
  • WVE Health Care
  • EIG Finance
  • Exchange
  • WVE Nasdaq
  • EIG Nasdaq
  • Market Cap
  • WVE 915.6M
  • EIG 1.0B
  • IPO Year
  • WVE 2015
  • EIG 2007
  • Fundamental
  • Price
  • WVE $8.29
  • EIG $42.61
  • Analyst Decision
  • WVE Strong Buy
  • EIG Strong Buy
  • Analyst Count
  • WVE 17
  • EIG 1
  • Target Price
  • WVE $19.94
  • EIG $58.00
  • AVG Volume (30 Days)
  • WVE 2.2M
  • EIG 178.9K
  • Earning Date
  • WVE 07-30-2025
  • EIG 10-29-2025
  • Dividend Yield
  • WVE N/A
  • EIG 3.01%
  • EPS Growth
  • WVE N/A
  • EIG N/A
  • EPS
  • WVE N/A
  • EIG 4.10
  • Revenue
  • WVE $93,946,000.00
  • EIG $889,500,000.00
  • Revenue This Year
  • WVE N/A
  • EIG $0.86
  • Revenue Next Year
  • WVE $10.02
  • EIG $0.80
  • P/E Ratio
  • WVE N/A
  • EIG $10.39
  • Revenue Growth
  • WVE N/A
  • EIG 2.32
  • 52 Week Low
  • WVE $5.04
  • EIG $38.19
  • 52 Week High
  • WVE $16.74
  • EIG $54.44
  • Technical
  • Relative Strength Index (RSI)
  • WVE 41.39
  • EIG 46.25
  • Support Level
  • WVE $7.12
  • EIG $42.29
  • Resistance Level
  • WVE $10.45
  • EIG $43.48
  • Average True Range (ATR)
  • WVE 0.54
  • EIG 0.65
  • MACD
  • WVE -0.24
  • EIG 0.16
  • Stochastic Oscillator
  • WVE 33.82
  • EIG 47.74

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About EIG Employers Holdings Inc

Employers Holdings Inc is a provider of workers' compensation insurance and services focused on small and mid-sized businesses engaged in low-to-medium hazard industries. Its customers are employers, and the insurance premiums that those employers pay to account for company revenue. Substantially all of the remaining revenue is generated through investments. The company operates exclusively in the United States, and it generates more than half of its business in California. By industry, the company has exposure to restaurants, which account for roughly a fourth of the total premiums the company earns. It operates as a single reportable segment, Insurance Operations, through its wholly owned subsidiaries.

Share on Social Networks: